Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
APXCF - Apex Critical Metals Corp. Announces Private Placement of Flow-Through Units to Raise Gross Proceeds of up to $1,000,000
XTMIF - XTM Provides Corporate Update and Announces Cease Trade Order
SNDL - SNDL Acquires Delta 9 Cannabis' Debt, Ascends to Senior Secured Creditor Status
WLDPF - Wildpack Announces Proposed Restructuring Transaction
Texas Instruments Inc (NASDAQ:TXN)
CM - CIBC donates $100,000 to Hurricane Beryl relief efforts
Great future $GTVH and $MMMW with recent news.
Enjoy the Day Everyone
be careful with fireworks
NAFS Financials are out. Grossprofit up to 34k...net loss down by 90% to just 50k...inventory/finished product (thus, ready for sale) eq. to 95k...much better than I expected! ...rock triple bottom pps
https://www.otcmarkets.com/otcapi/company/financial-report/406851/content
MMMW to Improve Financing and Sales of a New Product to be Announced on July 11
SNAX - Stryve Foods Appoints Former Frito-Lay Executive as Chairman
SWISF - New to The Street Celebrates the July 4th Holiday with Five Fantastic Business Interviews. Episode 579 Airs on Bloomberg TV as a Sponsored Programming on July 4, 2024, at 9:30 PM PT
CTHCF - CoTec Holdings Corp. Announces Non-Brokered Private Placement
GBLEF - Global Energy Metals to be Granted Uranium Royalty on Saskatchewan-Based Projects and Shares in Terra Balcanica
HZLIF - Hertz Energy Announces Termination of Option Assignment Agreement
SCNI - Scinai Immunotherapeutics Granted Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements
RAFA - Rafarma pharmaceutical updates: creation of a joint research and production enterprise in Busan (South Korea) between Rafarma and the Korean pharmaceutical company Woods Medical Care